Evidence map›Paper›PMID 33630351›Full record

ReviewCancer science2021

Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.

Kisato Nosaka, Masao Matsuoka

Open access · goldAbstract readReview
In one paragraph

Review in Cancer science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Regulation of HTLV-1 transformation.Bioscience reports · 2022
    Review
  9. Effective Utilization ofPlants (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Radiation Response of Human Leukemia/Lymphoma Cells was Improved by 7-Geranyloxycoumarin.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kisato NosakaDepartment of Hematology Rheumatology and Infectious Diseases, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0001-6682-2451
Masao MatsuokaDepartment of Hematology Rheumatology and Infectious Diseases, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-0473-754X
Kumamoto University · JP

Funding

JSPS KAKENHI 19H03689Project for Cancer Research And Therapeutic Evolution (P-CREATE) 20cm0106306h0005Research Program on Emerging and Re-emerging Infectious Diseases 20fk0108088h0002
6 · The paper itself

Abstract

Adult T-cell leukemia-lymphoma (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1) infection. Among HTLV-1 encoded genes, HTLV-1 bZIP factor (HBZ) and tax are critical for the leukemogenesis of ATL. Adult T-cell leukemia-lymphoma needs a long latent period before onset, indicating that both viral genes and alterations (genetic and epigenetic) of the host genome play important roles for leukemogenesis. Viral genes influence genetic and epigenetic changes of the host genome, indicating that the virus is of primary importance in leukemogenesis. HBZ is expressed in all ATL cases, whereas Tax expression is heterogeneous among ATL cases. Different patterns of viral gene expression in tumors are also observed for Epstein-Barr virus. We propose three subtypes of ATL cases based on Tax expression: high, intermittent, and lost expression. HBZ is detected in all ATL cases. Approximately 25% of all ATL cases lost Tax expression at infection of HTLV-1, indicating that HBZ is the only viral gene responsible for leukemogenesis in addition to genetic and epigenetic changes of the host genes in these ATL cases. The host immune responses to Tax are also implicated in the heterogeneity of ATL. Thus, ATL is a heterogeneous disease in terms of its viral gene expression, which is important for pathogenesis of this intractable lymphomatous neoplasm.

Indexed as

AnimalsAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBasic-Leucine Zipper Transcription FactorsB-LymphocytesCell ProliferationCell Transformation, ViralEpigenesis, GeneticForkhead Transcription FactorsGene Expression Regulation, LeukemicGene Expression Regulation, ViralGene Products, taxHerpesvirus 4, HumanHumansHuman T-lymphotropic virus 1Leukemia-Lymphoma, Adult T-CellAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBasic-Leucine Zipper Transcription FactorsEpstein-Barr virus encoded RNA 1Epstein-Barr virus encoded RNA 2Forkhead Transcription FactorsFOXP3 protein, humanGene Products, taxHBZ protein, human T-cell leukemia virus type ImogamulizumabRetroviridae ProteinsRNA, ViralATLCCR4CTLEBVHBZHTLV-1Tax

Identifiers

PMID33630351
PMCPMC8088923
OpenAlexW3130923351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.